Bupivacaina liposomal

Bupivacaína liposomal para tratar el dolor postoperatorio en artroplastia total unilateral The use of exparel (liposomal bupivacaine) to manage postoperative pain in unilateral total knee arthroplasty patients. Surdam JW, Licini DJ, Baynes NT, Arce BR. J Arthroplasty 2015 Feb;30(2):325-9. doi: 10.1016/j.arth.2014.09.004. Epub 2014 Sep 16. Abstract Efforts continue to improve pain after total knee arthroplasty (TKA) in order to allow for accelerated rehabilitation. The purpose of this study was to evaluate pain control after TKA. A randomized prospective study of 80 consecutive patients was performed comparing Exparel versus femoral nerve block (FNB). Inpatient pain control was the primary outcome. Secondary outcome measures included ROM (extension and flexion), nausea and vomiting, narcotic consumption, ambulation distance, and length of stay (LOS). There were no statistically significant differences between the groups with regard to pain, nausea and vomiting, and narcotic consumption. The FNB group had greater flexion but the Exparel group had improved early ambulation and decreased LOS. Exparel provided similar pain relief to a FNB after TKA without compromising early rehabilitation. KEYWORDS: accelerated rehabilitation; femoral nerve block; liposomal bupivacaine; total knee arthroplasty PDF Bupivacaína liposomal versus bupivacaína. Revisión comparativa Bupivacaine liposomal versus bupivacaine: comparative review. Noviasky J, Pierce DP, Whalen K, Guharoy R, Hildreth K5 Hosp Pharm. 2014 Jun;49(6):539-43. doi: 10.1310/hpj4906-539. Abstract Bupivacaine liposomal injection was recently approved by the US Food and Drug Administration (FDA) as a local anesthetic for use in management of postsurgical pain in adults. When compared to placebo, bupivacaine liposomal decreases postoperative pain and opioid use. This review examines the efficacy of bupivacaine liposomal when compared to conventional bupivacaine ± epinephrine using published and unpublished data provided to the FDA by the manufacturer. KEYWORDS: bupivacaine; bupivacaine liposomal; formulary; pharmacoeconomics PDF

Anestesiología y Medicina del Dolor 52 664 6848905 vwhizar@anestesia-dolor.org anestesia-dolor.org Copyright © 2015